Advocacy Letter to China National Drug Administration on Recommendation on the Management Adjustment to the Pudong Pilot Programme

2018-05-08 | Beijing

The European Chamber’s Cosmetics working groups submitted an advocacy letter to CNDA tore commend, based on the Pudong Pilot Program and under the guidance of the CNDA, Shanghai FDA, and by the implementation of Pudong Market Supervision Administration, before the program ends in 2018, a product safety evaluation report be used to replace animal testing in the materials submitted to notify an imported non-functional cosmetic product. This evaluative form can only be valid on the condition that the ‘responsible person’ (a term denoting corporate responsibility) will undertake all responsible precautionary measures to guarantee a product is safe and of good quality, to ensure a competent quality management system is established and to make sure onsite inspections of overseas manufacturing is doable.